Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 790,471 | 718,175 | 648,726 | 581,939 | 517,644 |
| Cost of Goods | 140,794 | 127,435 | 115,804 | 101,692 | 95,482 |
| Gross Profit | 649,677 | 590,740 | 532,922 | 480,247 | 422,162 |
| Operating Expenses | 534,369 | 474,463 | 435,547 | 403,683 | 354,428 |
| Operating Income | 116,102 | 116,712 | 98,179 | 77,256 | 68,216 |
| Interest Expense | 129 | 1 | 20 | 9 | 94 |
| Other Income | -320 | -130 | 267 | 231 | 742 |
| Pre-tax Income | 115,653 | 116,581 | 98,426 | 77,478 | 68,864 |
| Income Tax | 39,017 | 37,557 | 31,993 | 26,726 | 23,213 |
| Net Income Continuous | 76,636 | 79,024 | 66,433 | 50,752 | 45,651 |
| Net Income | $76,636 | $79,024 | $66,433 | $50,752 | $45,651 |
| EPS Basic Total Ops | 2.90 | 2.89 | 2.29 | 1.65 | 1.47 |
| EPS Basic Continuous Ops | 2.90 | 2.89 | 2.28 | 1.65 | 1.47 |
| EPS Diluted Total Ops | 2.80 | 2.78 | 2.23 | 1.63 | 1.43 |
| EPS Diluted Continuous Ops | 2.80 | 2.78 | 2.23 | 1.63 | 1.43 |
| EBITDA(a) | $124,912 | $125,756 | $107,005 | $85,730 | $76,132 |